VX-264 clinical trials

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

This study is looking at a new medicine called VX-264 for people with Type 1 Diabetes. We want to see if it's safe, how well people tolerate it, and if it helps manage the condition. It's for adults aged 18-65.